207 related articles for article (PubMed ID: 14645194)
21. Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5.
Blockeel C; Sterrenburg MD; Broekmans FJ; Eijkemans MJ; Smitz J; Devroey P; Fauser BC
J Clin Endocrinol Metab; 2011 Apr; 96(4):1122-8. PubMed ID: 21307142
[TBL] [Abstract][Full Text] [Related]
22. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
23. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
24. [Coordination of follicle antrum: from luteal estradiol to the premenstrual antagonist].
Fanchin R
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S21-3. PubMed ID: 15643681
[TBL] [Abstract][Full Text] [Related]
25. Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens.
Fanchin R; Cunha-Filho JS; Schonäuer LM; Kadoch IJ; Cohen-Bacri P; Frydman R
Fertil Steril; 2003 Feb; 79(2):316-21. PubMed ID: 12568840
[TBL] [Abstract][Full Text] [Related]
26. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol.
Fatemi HM; Camus M; Kolibianakis EM; Tournaye H; Papanikolaou EG; Donoso P; Devroey P
Fertil Steril; 2007 Mar; 87(3):504-8. PubMed ID: 17140572
[TBL] [Abstract][Full Text] [Related]
27. Acute follicular response to FSH in heifers downregulated long term with a GnRH agonist and with suppressed ovarian follicular growth.
D'Occhio MJ; Cremonesi F; Trigg TE; Aspden WJ; Baruselli PS
Theriogenology; 2013 Dec; 80(9):999-1005. PubMed ID: 23998741
[TBL] [Abstract][Full Text] [Related]
28. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.
Griesinger G; Verweij PJ; Gates D; Devroey P; Gordon K; Stegmann BJ; Tarlatzis BC
PLoS One; 2016; 11(3):e0149615. PubMed ID: 26950065
[TBL] [Abstract][Full Text] [Related]
29. Luteal estradiol pretreatment of poor and normal responders during GnRH antagonist protocol.
Sefrioui O; Madkour A; Kaarouch I; Louanjli N
Gynecol Endocrinol; 2019 Dec; 35(12):1067-1071. PubMed ID: 31142165
[TBL] [Abstract][Full Text] [Related]
30. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
31. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
[TBL] [Abstract][Full Text] [Related]
32. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study.
Blockeel C; De Vos M; Verpoest W; Stoop D; Haentjens P; Devroey P
Hum Reprod; 2009 Nov; 24(11):2910-6. PubMed ID: 19617207
[TBL] [Abstract][Full Text] [Related]
33. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
[TBL] [Abstract][Full Text] [Related]
34. Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a.
Karacan M; Erkan H; Karabulut O; Sarikamiş B; Camlibel T; Benhabib M
J Reprod Med; 2001 May; 46(5):485-9. PubMed ID: 11396377
[TBL] [Abstract][Full Text] [Related]
35. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study.
Huirne JA; van Loenen AC; Donnez J; Pirard C; Homburg R; Schats R; McDonnell J; Lambalk CB
Reprod Biomed Online; 2006 Aug; 13(2):235-45. PubMed ID: 16895639
[TBL] [Abstract][Full Text] [Related]
36. Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study.
Wei LH; Ma WH; Tang N; Wei JH
Taiwan J Obstet Gynecol; 2016 Feb; 55(1):50-4. PubMed ID: 26927248
[TBL] [Abstract][Full Text] [Related]
37. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist.
Ragni G; Vegetti W; Baroni E; Colombo M; Arnoldi M; Lombroso G; Crosignani PG
Hum Reprod; 2001 Nov; 16(11):2258-62. PubMed ID: 11679500
[TBL] [Abstract][Full Text] [Related]
38. Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration.
Barberi M; Ermini B; Morelli MB; Ermini M; Cecconi S; Canipari R
J Assist Reprod Genet; 2012 Dec; 29(12):1381-91. PubMed ID: 23188412
[TBL] [Abstract][Full Text] [Related]
39. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation.
Genro VK; Grynberg M; Scheffer JB; Roux I; Frydman R; Fanchin R
Hum Reprod; 2011 Mar; 26(3):671-7. PubMed ID: 21177311
[TBL] [Abstract][Full Text] [Related]
40. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
